Frontlight ResearchEarly access
HIV trials in Italy
11 of 25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Active, not recruitingA Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- Where
- Bergamo, Brescia, Genoa, Milan, Padova, Palermo, Pisa, Rome, Turin
- Age
- 18 years and over
- People
- 186 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07202546 · EU 2025-521918-26-00 - Phase 2Not yet taking people in ItalySemaglutide for the treatment of visceral obesity in people with HIV with body mass index <30 kg/m2 and without diabetes: a randomized clinical trial to explore immune metabolism, systemic and vascular inflammation assessed with Positron Emission Tomography
- Where
- Modena
- Age
- 18 years and over
- People
- 66
- Run by
- Azienda Ospedaliero Universitaria Di Modena
See details and how to join2026-526738-18-00 - Phase 3Not yet taking people in ItalyStudy of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
- Where
- Bergamo, Brescia, Genoa, Milan, Modena, Naples, Rome
- Age
- 18 years and over
- People
- 183 worldwide
- Run by
- Gilead Sciences Inc.
See details and how to join2025-524336-19-00 - Phase 3Active, not recruitingStudy to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
- Where
- Brescia, Foggia, Milan, Monza, Pavia, Rome
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Gilead Sciences Inc.
See details and how to joinNCT06333808 · EU 2023-510022-33-00 - Phase 2/3Taking peopleStudy of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
- Where
- Milan, Rome
- Age
- Up to 17 years
- People
- 17 worldwide
- Run by
- Gilead Sciences Inc.
See details and how to join2023-509428-16-00 - Phase 3Not yet taking people in ItalyStudy of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- Where
- Bari, Foggia, Milan, Monza, Pavia, Rome, Turin
- Age
- 18 years and over
- People
- 183 worldwide
- Run by
- Gilead Sciences Inc.
See details and how to join2025-524335-39-00 - No phaseTaking people#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
- Where
- Milan, Roma
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Casper Rokx
See details and how to joinNCT06900829 - Phase 2Not yet taking people in ItalyHIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
- Where
- Milan, Rome
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
See details and how to joinNCT04513626 · EU 2024-513941-35-00 - Phase 4Taking peopleStudy of the genetic, viral and immune response characteristics of a group of patients infected with the AIDS virus treated early and then subjected to suspension of antiretroviral therapy to define biological markers predicting the control of virus replication after pharmacological treatment
- Where
- Milan
- Age
- 18 years to 64 years
- People
- 100
- Run by
- Ospedale San Raffaele S.r.l.
See details and how to join2024-515419-24-00 - Phase 3Active, not recruitingEfficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
- Where
- Turin
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Chelsea and Westminster NHS Foundation Trust
See details and how to joinNCT04892654 · EU 2023-509751-14-03 - Phase 2Not yet taking people in ItalyNivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome
- Where
- Verona
- Age
- 18 years to 75 years
- People
- 105
- Run by
- Universita di Verona
See details and how to joinNCT05597800